How shall we treat locally advanced triple negative breast cancer? [version 2; peer review: 2 approved]
Triple negative breast cancer (TNBC) has been shown to respond to neoadjuvant chemotherapy (NACT). It has been established that achieving pathological complete response (pCR) for certain aggressive subtypes of breast cancer, including HER-2 (over-expressed) and TNBC, provides an important surrogate...
Main Authors: | Paulo Luz, David Dias, Ana Fortuna, Luis Bretes, Beatriz Gosalbez |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-05-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-1649/v2 |
Similar Items
-
Triple-negative breast cancer: recent treatment advances [version 1; peer review: 2 approved]
by: Alice R T Bergin, et al.
Published: (2019-08-01) -
Open Science Training in TRIPLE [version 2; peer review: 1 approved, 2 approved with reservations]
by: Lottie Provost, et al.
Published: (2023-06-01) -
Open Science Training in TRIPLE [version 1; peer review: 1 approved, 2 approved with reservations]
by: Lottie Provost, et al.
Published: (2023-02-01) -
SHALL WE DANCE? /
by: Michaels, Kasey
Published: (2005) -
Shall We Dance?
by: Margareta Sörenson
Published: (2016-06-01)